Inflammation-nutritional markers of peripheral blood could predict survival in advanced non-small-cell lung cancer patients treated with PD-1 inhibitors.
Dan PuQian XuLai-Yan ZhouYu-Wen ZhouJi-Yan LiuXue-Lei MaPublished in: Thoracic cancer (2021)
Our research illustrated that pretreatment AEC, AMC, ALB, NLR, and PLR are independent predictors for survival in advanced NSCLC patients treated with PD-1 inhibitors.